Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 3/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | IDO1 | P14902 | 2/20 | 0.46 |
| ▸ | GAA | P10253 | 2/20 | 0.41 |
| ▸ | GLA | P06280 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.40 |
| ▸ | ACHE | P22303 | 2/20 | 0.38 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | KDM1A | O60341 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.36 |
| ▸ | CA12 | O43570 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | CA4 | P22748 | 1/20 | 0.35 |
| ▸ | CA6 | P23280 | 1/20 | 0.35 |
| ▸ | CA5A | P35218 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29978561 | 1.00 | KIF11 (0.48) | KIF11ALDH1A1IDO1GAAGLA | |
| SCHEMBL185520 | 0.81 | ALDH1A1 (0.52) | KIF11ALDH1A1IDO1GAAGLA | |
| SCHEMBL14443262 | 0.79 | ALDH1A1 (0.44) | KIF11ALDH1A1GAAKEAP1HTT | |
| Hydrochloric Acid SCHEMBL8996706 | 0.79 | IDO1 (0.52) | KIF11ALDH1A1IDO1GAAGLA | |
| Hydrochloric Acid SCHEMBL4372850 | 0.79 | IDO1 (0.52) | KIF11ALDH1A1IDO1GAAGLA | |
| SCHEMBL711538 | 0.78 | TSHR (0.60) | KIF11ALDH1A1GAAGLAPOLB | |
| SCHEMBL29460325 | 0.78 | TSHR (0.60) | KIF11ALDH1A1GAAGLAPOLB | |
| SCHEMBL8174858 | 0.78 | KIF11 (0.61) | KIF11ALDH1A1GAAGLAPOLB | |
| SCHEMBL7601736 | 0.77 | IDO1 (0.50) | KIF11IDO1GAAGLAPOLB | |
| SCHEMBL330502 | 0.76 | ALDH1A1 (0.52) | KIF11ALDH1A1GAAGLAPOLB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022228449-A1 | PREPARATION METHOD FOR POLYIMIDE RESIN AND THIN FILM THEREOF | 上海瑞暨新材料科技有限公司 | 2022-11-03 | — | — | WO | claimed |
| CN-113201136-B | Preparation method of polyimide resin and film thereof | 上海瑞暨新材料科技有限公司 | 2022-01-07 | — | — | CN | claimed |
| CN-113201136-A | Preparation method of polyimide resin and film thereof | 上海瑞暨新材料科技有限公司 | 2021-08-03 | — | — | CN | claimed |
| WO-2023118267-A1 | NOVEL GALACTOSIDE INHIBITOR OF GALECTINS | GALECTO BIOTECH AB (DK) | 2023-06-29 | — | — | WO | disclosed |
| WO-2022228449-A1 | PREPARATION METHOD FOR POLYIMIDE RESIN AND THIN FILM THEREOF | 上海瑞暨新材料科技有限公司 | 2022-11-03 | — | — | WO | disclosed |
| CN-113201136-B | Preparation method of polyimide resin and film thereof | 上海瑞暨新材料科技有限公司 | 2022-01-07 | — | — | CN | disclosed |
| EP-3433234-B1 | ALLOSTERIC MODULATORS OF NICOTINIC ACETYLCHOLINE RECEPTORS | MERCK SHARP & DOHME (US) | 2021-10-27 | — | — | EP | disclosed |
| CN-113201136-A | Preparation method of polyimide resin and film thereof | 上海瑞暨新材料科技有限公司 | 2021-08-03 | — | — | CN | disclosed |
| US-10158092-B2 | Organic electronic component with dopant, use of a dopant and method for the production of the dopant | OSRAM OLED GMBH (DE) | 2018-12-18 | — | — | US | disclosed |
| EP-2768926-B1 | ORGANIC ELECTRONIC COMPONENT WITH DOPANT, USE OF A DOPANT AND METHOD FOR THE PRODUCTION OF THE DOPANT | OSRAM OLED GMBH (DE) | 2018-09-19 | — | — | EP | disclosed |
| US-20180108849-A1 | Organic Electronic Component with Dopant, Use of a Dopant and Method for the Production of the Dopant | OSRAM OLED GMBH (DE) | 2018-04-19 | — | — | US | disclosed |
| CN-102952039-A | Synthesis method of 4-chloro-2-trifluoromethylbenzonitrile | DALIAN JOIN KING BIOLOG CHEMICAL TECHNOLOGY CO LTD | 2013-03-06 | — | — | CN | disclosed |
| CN-102414177-A | Compounds as bradykinin b1 antagonists | BOEHRINGER INGELHEIM INT | 2012-04-11 | — | — | CN | disclosed |
| EP-2401256-A1 | COMPOUNDS AS BRADYKININ B1 ANTAGONISTS | Boehringer Ingelheim International GmbH (DE) | 2012-01-04 | — | — | EP | disclosed |
| US-20100240669-A1 | NEW COMPOUNDS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2010-09-23 | — | — | US | disclosed |
| WO-2010097372-A1 | COMPOUNDS AS BRADYKININ B1 ANTAGONISTS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2010-09-02 | — | — | WO | disclosed |
| EP-1953147-A1 | HETEROCYCLIC COMPOUND AND MEDICINAL APPLICATION THEREOF | Japan Tobacco, Inc. (JP) | 2008-08-06 | — | — | EP | disclosed |
| EP-0315863-B1 | Trifluoromethylamino benzenes containing fluorine, and their preparation | BAYER AG (DE) | 1993-11-18 | — | — | EP | disclosed |
| US-5082971-A | TRIFLUOROMETHYLAMINOBENZENES CONTAINING FLUORINE AND/OR CHLORINE AND THEIR PREPARATION | BAYER AKTIENGESELLSCHAFT (DE) | 1992-01-21 | — | — | US | disclosed |
| EP-0315863-A2 | Trifluoromethylamino benzenes containing fluorine, and their preparation | BAYER AG (DE) | 1989-05-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10158092-B2 | Organic electronic component with dopant, use of a dopant and method for the production of the dopant | AOC2, DDT, AOC1 | KIF11 3961/4885ALDH1A1 794/4885IDO1 181/4885 |
| US-20180108849-A1 | Organic Electronic Component with Dopant, Use of a Dopant and Method for the Production of the Dopant | TYR, DDT, AOC2 | KIF11 3886/4885ALDH1A1 342/4885IDO1 18/4885 |
| US-20100240669-A1 | NEW COMPOUNDS | ADORA1, H1-10, P2RY11 | KIF11 2637/4885ALDH1A1 1000/4885IDO1 3069/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.